Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
Gencove low-pass sequencing platform
Gencove's low-pass sequencing platform is the most efficient solution for genomic discovery. Start sequencing and increase the power and scale of your genomic projects.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen November 2026 · 1 capture · latest observed messagingGet your genetic baseline for $69
Get deep genetic insights for just $69. Powered by low-pass whole genome sequencing with full access to your raw data.
August 2018 – July 2019 · 2 capturesGencove low-pass sequencing platform
Gencove's low-pass sequencing platform is the most efficient solution for genomic discovery. Start sequencing and increase the power and scale of your genomic projects.
6 August 2018 · Gencove low-pass sequencing platformarchived page
21 July 2019 · Gencove low-pass sequencing platformarchived page
Companies in the same space
Competitors picked by an AI model from the funded startups with the most similar descriptions, judged on those descriptions only. A reading, not a verified market map.
Nebula Genomicsnebula.orgDirect competitorBoth offer affordable consumer whole-genome sequencing with downstream analysis and data access.